INMB — Inmune Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Inmune Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7	22	74.8	52.2	35.8
Net Total Receivables	0.645	1.8	5.5	8.46	2.44
Prepaid Expenses
Total Current Assets	7.76	24	82.6	64.7	39.9
Net Property, Plant And Equipment	0.192	0.156	0.726	0.507	0.414
Net Intangible Assets
Other Long Term Assets
Total Assets	24.5	40.7	99.9	81.8	57
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.7	1.78	4.36	10.9	18.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.861	1.9	19.7	21.7	18.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	23.6	38.8	80.2	60.1	38.1
Total Liabilities & Shareholders' Equity	24.5	40.7	99.9	81.8	57
Total Common Shares Outstanding